According to the success of MSC-derived exosome therapy against ischemic strokes, Xia et al. have revealed that in ischemic strokes, iMSC-derived exosomes could improve angiogenesis, potentially via STAT3 activation-mediated autophagy inhibition [122]. This evidence concerns the gene STAT3 and ischemic stroke.